Endothelial dysfunction in diabetes
Open accessThe DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index, and 1 are not checked yet.
Abstract
Endothelial dysfunction plays a key role in the pathogenesis of diabetic vascular disease. The endothelium controls the tone of the underlying vascular smooth muscle through the production of vasodilator mediators. The endothelium‐derived relaxing factors (EDRF) comprise nitric oxide (NO), prostacyclin, and a still elusive endothelium‐derived hyperpolarizing factor (EDHF). Impaired endothelium‐dependent vasodilation has been demonstrated in various vascular beds of different animal models of diabetes and in humans with type 1 and 2 diabetes. Several mechanisms of endothelial dysfunction have been reported, including impaired signal transduction or substrate availibility, impaired release of EDRF, increased destruction of EDRF, enhanced release of endothelium‐derived constricting factors and decreased sensitivity of the vascular smooth muscle to EDRF. The principal mediators of hyperglycaemia‐induced endothelial dysfunction may be activation of protein kinase C, increased activity of the polyol pathway, non‐enzymatic glycation and oxidative stress. Correction of these pathways, as well as administration of ACE inhibitors and folate, has been shown to improve endothelium‐dependent vasodilation in diabetes. Since the mechanisms of endothelial dysfunction appear to differ according to the diabetic model and the vascular bed under study, it is important to select clinically relevant models for future research of endothelial dysfunction. British Journal of Pharmacology (2000) 130 , 963–974; doi: 10.1038/sj.bjp.0703393
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both hyperglycemia and hyperinsulinemia alter the endothelium,27 disrupting the normal atheroprotective nitric oxide regulatory environment and encouraging a generalized proinflammatory, vasoconstrictive state predisposing to atherothrombosis.27–29”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [28]
Experimental — accuracy not yet measuredIn the citing paper
“Impaired endothelium-dependent vasodilation has been demonstrated in various vascular beds of animal models of diabetes and humans with type 1 and type 2 diabetes (80).”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [80]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441 · cited 1×
“Although AGE formation occurs during the normal ageing process, it is markedly accelerated during diabetes, as a consequence of an increase in substrate, e.g. glucose, and in the prevailing oxidant stress in this disease (Baynes & Thorpe, 1999).”
BackgroundEndothelium‐derived relaxing and contracting factors
Furchgott, R. F., & Vanhoutte, P. M. (1989) · The FASEB Journal · doi:10.1096/fasebj.3.9.2545495 · Cited by 1,993
Self-citationOxidative Stress and Diabetic Vascular Complications
Giugliano, D., Ceriello, A., & Paolisso, G. (1996) · Diabetes Care · doi:10.2337/diacare.19.3.257 · Cited by 1,930
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Wolff, S. P., & Dean, R. T. (1987) · Biochemical Journal · doi:10.1042/bj2450243 · Cited by 1,271
Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor
Rubanyi, G. M., & Vanhoutte, P. M. (1986) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1986.250.5.h822 · Cited by 1,188
Self-citationBucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Research works printed but not linked: 6
- DE VRIESE A., 1999, Impaired endothelium‐derived hyperpolarizing factormediated renal vasodilatory response in diabetes: restoration with folate, J. Am. Soc. Nephrol., 10, 394A
- FRIEDMAN E.A., 1999, Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications, Diabetes Care, 22, B65
- FULTON D., 1996, Cytochrome P450 arachidonate metabolites: deficit in diabetes mellitus, FASEB J., 9, A113
- QUILLEY J., 1996, NO‐independent coronary vasodilation to bradykinin in diabetes, Hypertension, 28, P178
- 10.2337/diabetes.42.9.1246 · doi:10.2337/diabetes.42.9.1246
- 10.1042/cs19980382 · doi:10.1042/cs19980382
Cited by
Items 901–1,000 of 1,000
Altınok, A., Coşkun, Z. M., Karaoğlu, K., Bolkent, S., Akkan, A. G., & Özyazgan, S. (2015) · Acta Physiologica Hungarica · doi:10.1556/aphysiol.102.2015.1.5 · Cited by 6
Bansal, S., Kare, P. K., Tripathi, A. K., & Madhu, S. V. (2019) · Springer eBooks · doi:10.1007/978-981-13-8273-4_20 · Cited by 6
Matsumoto, T., Ozawa, Y., Taguchi, K., Kobayashi, T., & Kamata, K. (2009) · Journal of Smooth Muscle Research · doi:10.1540/jsmr.45.197 · Cited by 6
“…of blood vessels to neurotransmitters and hormones) is a well-established complication of diabetes mellitus (Kamata et al., 1989; Hattori et al., 1991; Poston and Taylor, 1995; De Vriese et al., 2000; Kobayashi et al., 2000, 2004, 2005; Cohen, 2005; Matsumoto et al., 2003a, b, 2004, 2005, 2008a).”
BackgroundOsma, M. D. C. I., Torres, M. A., García‐Barrado, M. J., & Moratinos, J. (2008) · Revista Clínica Española · doi:10.1157/13119918 · Cited by 6
Pathogenetic mechanisms of diabetic microangiopathy
Mario, U. D. (2003) · International Congress Series · doi:10.1016/s0531-5131(03)00145-6 · Cited by 6
Papežíková, I., Pekarová, M., Chatzopoulou, M., Nicolaou, I., Demopoulos, V. J., Kubala, L., & Lojek, A. (2008) · PubMed · Cited by 6
Aminoguanidine Suppresses Basal Macromolecular Extravasation during Diabetes Mellitus
Mayhan, W. G., & Sharpe, G. M. (2000) · Microvascular Research · doi:10.1006/mvre.1999.2194 · Cited by 6
Srikumar, B. N., Shastri, S., Ramarao, P., & Kaul, C. L. (2003) · Progress in experimental cardiology · doi:10.1007/978-1-4419-9232-1_26 · Cited by 6
“Superoxide radical levels are increased in diabetes [6] and in this study, we have shown that Ang II might induce the production of superoxide radicals in diabetic aorta.”
BackgroundInfluentialCutruzzolà, A., Parise, M., Cacia, M. A., Lucà, S., Irace, C., & Gnasso, A. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02313-1 · Cited by 5
“In diabetes, NO bioavailability is reduced due to the increased oxidative stress and inflammatory state within the vascular endothelium, as a consequence of chronic hyperglycemia [5].”
BackgroundHuang, M., Chang, J., Liu, Y., Yin, J., & Zeng, X. (2024) · Peptides · doi:10.1016/j.peptides.2024.171333 · Cited by 5
Indole metabolism and its role in diabetic macrovascular and microvascular complications
Hu, W., Garrison, C., Prasad, R., Boulton, M., & Grant, M. B. (2025) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2025.100532 · Cited by 5
“In the endothelial cells, hyperglycemia impairs production of nitric oxide (NO) via decreased eNOS synthase activation and increased ROS production [62].”
Jimenez‐Trinidad, F. R., Solanes, N., Arrieta, M., Llonch, B., Roqué, M., Freixa, X., Brugaletta, S., Ortega‐Paz, L., Rodríguez, J. J., Guillén, P. L. C., et al. (2025) · Angiogenesis · doi:10.1007/s10456-025-10006-8 · Cited by 5
Microvascular Consequences of Obesity and Diabetes
Bohlen, H. G. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374530-9.00021-8 · Cited by 5
Аржиматова, Г. Ш., Hejlo, T. S., Novova, N. L., & Suchkova, O. V. (2019) · Russian Annals of Ophthalmology · doi:10.17116/oftalma201913502155 · Cited by 5
Srivastava, P., Badhwar, S., Chandran, D. S., Jaryal, A. K., Jyotsna, V. P., & Deepak, K. K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.06.043 · Cited by 5
Restricted Intimal Ca2+ Signaling Associated With Cardiovascular Disease
Taylor, M. S., Lowery, J., Choi, C., & Francis, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.848681 · Cited by 5
Razan, M. R., Amissi, S., Islam, R. A., Graham, J. L., Stanhope, K. L., Havel, P. J., & Rahimian, R. (2023) · Biomedicines · doi:10.3390/biomedicines11041129 · Cited by 5
Campos, R. D. M., Lima, L. M. A. L. L., da Silva, A. G., Santiago, R. O., Paz, I. A., Cabral, P. H. B., Santos, C. F., Fonteles, M. C., & do Nascimento, N. R. F. (2023) · Research in Veterinary Science · doi:10.1016/j.rvsc.2023.06.020 · Cited by 5
Afzal, S., Sattar, M. A., Akhtar, S., Abdullah, N. A., Eseyin, O. A., Abdulla, M. H., & Johns, E. J. (2018) · Pakistan Journal of Pharmaceutical Sciences · doi:10.36721/pjps/31/3/03.05.2018/4005/747-754 · Cited by 5
Cardiovascular Manifestations of Hyperglycemia: A Review Article
Giquel, J., Nieto, M., & Matadial, C. M. (2014) · Journal of General Practice · doi:10.4172/2329-9126.1000191 · Cited by 5
“Several studies have shown that endothelial cell dysfunction is characterized by impaired NO-mediated vasodilation and increased synthesis of vasoconstrictor prostanoids and endothelin [11-14].”
BackgroundChronic oral Silybum Marianum aqueous extract attenuates streptozotocin-diabetic neuropathy
Baluchnejadmojarad, T., & Roghani, M. (2009) · Journal of Diabetes & Metabolic Disorders · Cited by 5
Rao, G. S. N., Gurumurthy, P., Gururajan, P., SaiBabu, R., & Cherian, K. M. (2011) · Pediatrics International · doi:10.1111/j.1442-200x.2010.03191.x · Cited by 5
Chu, F. J., Jin, X. B., Xu, Y. Y., Ma, Y., Li, X. B., Lu, X. M., Liu, W. B., & Zhu, J. Y. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000343377 · Cited by 5
Hemoglobin infusion does not alter murine pulmonary vascular tone
Beloiartsev, A., Baron, D. M., Yu, B., Bloch, K. D., & Zapol, W. M. (2013) · Nitric Oxide · doi:10.1016/j.niox.2012.12.007 · Cited by 5
“Systemic endothelial dysfunction is frequently associated with metabolic disorders such as diabetes [19] and is characterized by impaired generation of NO by endothelial cells [20].”
BackgroundMalardé, L., Rébillard, A., Lahaye, S. L. D., Vincent, S., Zguira, M. S., Lemoine-Morel, S., Gratas‐Delamarche, A., & Groussard, C. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1932-z · Cited by 5
“Although the mechanisms responsible for vascular dysfunction have not been completely elucidated, the oxidant stress (OS) has been recognized as an important factor, through the endothelial NO synthase (eNOS) uncoupling or the nitric oxide ( NO) inactivation triggered by the superoxide anion (O2 ) [1].”
BackgroundSabri, M. R., Tavana, E. N., Ahmadi, A., & Hashemipour, M. (2014) · PubMed Central · Cited by 5
Nonvital Bleaching: A Case Series on whitening Procedure for Discolored Endodontically Treated Teeth
Agarwal, M., Narang, A., Awadhiya, S., & Jain, M. (2014) · International Journal of Prosthodontics and Restorative Dentistry · doi:10.5005/jp-journals-10019-1198 · Cited by 5
Davì, G., Santilli, F., & Vazzana, N. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00035-3 · Cited by 5
Nicolas, J., Razuk, V., Giustino, G., & Mehran, R. (2021) · Future Cardiology · doi:10.2217/fca-2021-0014 · Cited by 5
Sonobe, T., Tsuchimochi, H., Maeda, H., & Pearson, J. T. (2022) · The Journal of Physiology · doi:10.1113/jp282981 · Cited by 5
“The Journal of Physiology © 2022 The Physiological Society. et al., 2021; Weston et al., 2008; Young et al., 2008), in parallel with a blunted nitric oxide (NO)-mediated smooth muscle relaxation (De Vriese et al., 2000; Eringa et al., 2007; Guzik et al., 2002; Leo et al., 2011).”
BackgroundHamed, S. A., El-kossi, A. E. A., Abdellah, M. M., & Rashad, A. M. (2011) · Journal of Clinical and Experimental Investigations · doi:10.5799/ahinjs.01.2011.03.0049 · Cited by 5
Yılmaz, B., Sahin, P., Güngör‐Ordueri, N. E., Çelik-Özenci, Ç., & Taşatargil, A. (2014) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2014.908253 · Cited by 5
Sartoretto, J. L., Santos, R. A. S., Scavone, C., Tostes, R. C., Nigro, D., de Carvalho, M. H. C., Cuman, R. K. N., & Fortes, Z. B. (2007) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.59.8.0009 · Cited by 5
“Impaired endothelium-dependent and endothelium-independent relaxation has been reported in different types of blood vessels and in different animal models of diabetes (De Vriese et al 2000).”
BackgroundGeneration of Superoxide Anion Impairs Histamine-Induced Increases in Macromolecular Efflux
Mayhan, W. G., & Sharpe, G. M. (2001) · Microvascular Research · doi:10.1006/mvre.2001.2313 · Cited by 5
Nitric oxide synthase in skeletal muscle fibers of patients with type 2 diabetesPreprint
Punkt, K., Kandt, K., Oberbach, A., Adams, V., Buchwalow, I., & Blüher, M. (2012) · Nature Precedings · doi:10.1038/npre.2012.7049.1 · Cited by 5
Microvascular Alterations in Diabetes: Focus on Small Resistance Arteries
Ciuceis, C. D. (2020) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-030-47801-8_12 · Cited by 4
Voronkov, A. V., Lysenko, A. S., & Bandura, A. F. (2018) · Health Risk Analysis · doi:10.21668/health.risk/2018.1.11.eng · Cited by 4
Han, K., Li, X., Li, M., Liu, T., Liu, F., Yang, J., Jin, S., Liu, J., Liu, J., Hao, Y., et al. (2024) · Annals of Medicine · doi:10.1080/07853890.2024.2419546 · Cited by 4
“…elevated glucose levels may decrease nitric oxide production and increase endothelial superoxide species and vasoconstrictor production [36,37]. elevated glucose levels may increase the production of prothrombotic tissue factor and increase platelet activation and aggregation [38,39].…”
BackgroundOxidative Stress and Novel Antioxidant Approaches to Reduce Diabetic Complications
Min, S., Sharma, A., & de H, J. B. (2012) · InTech eBooks · doi:10.5772/35020 · Cited by 4
“One way in which hyperglycaemia attenuates the level of EDNO is by blocking the function of endothelial NOS (eNOS) synthase in endothelial and vascular smooth muscle cells (De Vriese et al 2000).”
BackgroundParsaee, H., Imenshahidi, M., & Fatehi, Z. (2006) · Iranian journal of pharmaceutical research · doi:10.22037/ijpr.2010.674 · Cited by 4
Pathophysiologic mechanisms involved in genital arousal dysfunction
Kim, N. N. (2005) · CRC Press eBooks · doi:10.1201/b14618-30 · Cited by 4
Kvitnitskaya-Ryzhova, T., Lugovskoy, S., Klymenko, P. P., Mykhalskiy, S., Khablak, G., & Toporova, O. K. (2018) · Cell and Organ Transplantology · doi:10.22494/cot.v6i1.81 · Cited by 4
“Of particular interest are endothelial injuries the due to the special role of endothelial dysfunction in the pathogenesis of diabetes [8, 11-13].”
BackgroundFuruta, M., Ueyama, M., Morita, S., Yamana, A., & Sanke, T. (2012) · Journal of Diabetes Investigation · doi:10.1111/jdi.12021 · Cited by 4
Complications in diabetic patients undergoing revision total joint arthroplasty
Mazoch, M. J., Barnes, C. L., & Cooper, K. B. (2016) · Current Orthopaedic Practice · doi:10.1097/bco.0000000000000360 · Cited by 4
Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease
Bonds, J. A., Hart, P. C., Minshall, R. D., Lazarov, O., Haus, J. M., & Bonini, M. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802851-3.00013-9 · Cited by 4
Effect of Hyperglycemia on the Excretory Ducts of the Submandibular Gland (Histologic Study)
Ersteniuk, H., Kotyk, T., Dey, N., Yurakh, O., & Popadynets, O. H. (2016) · Galician Medical Journal · doi:10.21802/gmj.2016.4.9 · Cited by 4
“Hyperglycemia affects structural components of various organs and systems in different ways, namely through activating the sorbitol pathway and protein kinase C, increasing oxidative stress, reducing the levels of vasodilators, changing Na+, K+-ATPase activity or causing non-enzymatic glycation of proteins [6, 7].”
BackgroundFan, W., Zhang, R., Han, D. H., Jiang, Z., Li, S., Zhang, J., Lǐ, Y., Wang, Y., & Cao, F. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15201 · Cited by 4
Insuficiencia cardíaca y diabetes
Thierer, J. M. (2026) · Revista Argentina de Cardiología · doi:10.7775/rac.v74i1.2642 · Cited by 4
“(12, 22) La hiperglucemia y los productos glicosilados terminales también son responsables de la progresión de la enfermedad aterosclerótica.”
Takenouchi, Y., Kobayashi, T., Taguchi, K., Matsumoto, T., & Kamata, K. (2010) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y10-045 · Cited by 4
Bosevski, M., & Georgievska‐Ismail, L. (2010) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2010.2699 · Cited by 4
Sridulyakul, P., Wongeakin, N., & Patumraj, S. (2010) · Asian Biomedicine · doi:10.5372/913 · Cited by 4
“For both human and animal diabetic models, decreased eNOS-associated NO bioavailibity is a possible factor responsible for diabetes-induced endothelial dysfunction [4, 5].”
BackgroundRelationship Between Vascular Endothelial Growth Factor and Interleukin-6 in Diabetic Retinopathy
., A. A. B., Arafa, L. F., & Ghanem, A. A. (2004) · Pakistan Journal of Biological Sciences · doi:10.3923/pjbs.2004.1858.1864 · Cited by 4
Arıcan, N., Kaya, M., Kalaycı, R., Küçük, M., Cimen, V., & Elmas, İ. (2002) · Forensic Science International · doi:10.1016/s0379-0738(01)00629-6 · Cited by 4
Tare, M., Coleman, H. A., & Parkington, H. C. (2003) · Neurophysiology · doi:10.1023/b:neph.0000008786.79520.95 · Cited by 4
“The effects of diabetes on NO-mediated vasodilation have been extensively reviewed [3-6, 14].”
BackgroundMalardé, L. (2012) · theses.fr (ABES) · doi:10.70675/3e7afc67z078cz4a9cz8503z1d7f7d9a289b · Cited by 4
Takayama, A., Yoshida, S., & Kawakami, K. (2024) · Journal of Internal Medicine · doi:10.1111/joim.20012 · Cited by 3
António, N., Soares, F., Lourenço, C., Saraiva, F., Gonçalves, F., Monteiro, P. F., Gonçalves, L. M. M., Freitas, M., & Providência, L. A. (2010) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302010000700005 · Cited by 3
“2010;54/7 Insulin appears to exert multiple beneficial effects on endothelial cells, platelet and leukocyte function, which could be potentially cardioprotective and antiatherosclerotic (23-25).”
BackgroundYoshino, J., Akata, T., Shirozu, K., Izumi, K., & Hoka, S. (2010) · Anesthesiology · doi:10.1097/aln.0b013e3181ce9e80 · Cited by 3
“Because the vasodilator response to acetylcholine in rat small mesenteric artery is mediated by both nitric oxide and EDHF,(21) its impairment is likely due to the decreased nitric oxide or EDHF activity associated with diabetes.(13) It is believed that the impaired vasoregulatory role of endothelium is an initiating…”
BackgroundKhan, S. Z., Shaikh, R., Azhar, M., Wali, A., & Ahmad, J. (2018) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.1000789 · Cited by 3
“His study suggested that the significant association of DD genotype with DPN while in their study II genotype was more frequent in control group suggesting the protective role of this genotype in development of DM and DPN [1].”
BackgroundArterial Stiffness Is Associated With QTc Interval Prolongation in Patients With Heart Failure
Al‐Zaiti, S. S., Saba, S., Pike, R., Williams, J. K., & Khraim, F. (2017) · Biological Research For Nursing · doi:10.1177/1099800417737835 · Cited by 3
Abdallah, H. M., Halawany, A. M. E., & El‐Bassossy, H. M. (2019) · Phytochemistry Letters · doi:10.1016/j.phytol.2019.04.015 · Cited by 3
The association of GFPT2 and Glu 298 Asp gene variations to the type 2 diabetes
Alghanimi, Y. K., & no, N. (2020) · Gene Reports · doi:10.1016/j.genrep.2019.100579 · Cited by 3
Bisseling, T. M., Wouterse, A. C., Steegers, E. A. P., Elving, L. D., Rüssel, F. G. M., & Smits, P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01437.x · Cited by 3
ENDOTHELIUM-DEPENDENT VASCULAR REACTIVITY IN DIABETES MELLITUS TYPE 2
Nikolaev, К. Y., Bairamova, S. S., Васильевна, Ц. О., & Lyfshits, G. I. (2017) · Journal of clinical practice · doi:10.17816/clinpract8461-65 · Cited by 3
Mishra, S., Chowdhary, R., & Pachimalla, P. R. (2014) · International Journal of Prosthodontics and Restorative Dentistry · doi:10.5005/jp-journals-10019-1197 · Cited by 3
Pattipati, M., Gudavalli, G., & Dhulipalla, L. (2022) · Cureus · doi:10.7759/cureus.25157 · Cited by 3
Effect of Carotid Body Denervation on Systemic Endothelial Function in a Diabetic Animal Model
Cabral, M. D., Martins, F. O., Martins, I. B., Melo, B. F., Sacramento, J. F., Conde, S. V., & Prieto‐Lloret, J. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-32371-3_13 · Cited by 3
Impaired Vascular BK Channel Function in Type 2 Diabetes Mellitus
Lü, T., & Lee, H.-C. (2011) · InTech eBooks · doi:10.5772/22077 · Cited by 3
“…and thromoxane A2 (TXA2), and reduced activity/bioavailability of endothelium-derived relaxing factors (EDRFs) such as nitric oxide (NO), carbon monoxide (CO), prostacyclin (PGI2) and endothelium-derived hyperpolarizing factors (EDHFs) (Avogaro et al., 2006; De Vriese et al., 2000; Xu & Zou, 2009).”
Nakhai, I., Hossein, A., & Gholami, S. (2010) · InTech eBooks · doi:10.5772/8599 · Cited by 3
Kamper, A. M., de Craen, A. J. M., Westendorp, R. G. J., & Blauw, G. J. (2005) · PubMed Central · Cited by 3
Punzi, S., Belloli, C., Gogny, M., Desfontis, J., & Mallem, Y. (2015) · The Veterinary Journal · doi:10.1016/j.tvjl.2015.10.007 · Cited by 3
“…an initiating factor in many progressive vasculopathies in humans, including pulmonary hypertension, diabetic vasculopathies and atherosclerosis (De Vriese et al., 2000; Feher et al., 2014; Martin-Ramirez et al., 2014; White et al., 2014) as well as in laminitis in animals (Boosman et al., 1991;…”
BackgroundImpaired endothelium-dependent and -independent relaxation of aorta from diabetic rats
Yakubu, M. A., Sofola, O. A., Igbo, I., & Oyekan, A. (2012) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2012_014 · Cited by 3
“Such assumptions often lead to con fl icting conclusions (De Vriese et al, 2000).”
Артеријска хипертензија гојазне деце и адолесцената
Peco‐Antić, A. (2009) · Cited by 3
Oxidative Stress and Diabetes-Induced Vascular Dysfunction: Role in Diabetic Neuropathy
Yorek, M. A. (2014) · Oxidative stress in applied basic research and clinical practice · doi:10.1007/978-1-4899-8035-9_1 · Cited by 3
da Rosa, M. P., Baroni, G. V., & Portal, V. L. (2007) · Arquivos Brasileiros de Endocrinologia & Metabologia · doi:10.1590/s0004-27302007000900017 · Cited by 3
Cardiovascular risk in diabetic women
Bolego, C., Poli, A., & Paoletti, R. (2003) · Current Atherosclerosis Reports · doi:10.1007/s11883-003-0074-2 · Cited by 3
“Together, these effects contribute to vascular dysfunction, which represents the initial step of the formation of atherosclerotic lesions in diabetes [ 8 ,9].”
BackgroundOwu, D. U., Orie, N. N., Nwokocha, C. R., Muzyamba, M. C., Clapp, L. H., & Osim, E. E. (2013) · General Physiology and Biophysics · doi:10.4149/gpb_2013057 · Cited by 3
“Increased production of ROS in the vasculature has also been linked to impairment of nitric oxide (NO)mediated endothelium-dependent vasodilation (Olukman et al. 2010; Spitaler and Graier 2002) in both diabetic humans and animals (De Vriese et al. 2000; Pieper et al. 2002).”
BackgroundLos productos de Amadori como mediadores de disfunción endotelial en la diabetes mellitus
Sánchez, C., Peiró, C., & Rodríguez, L. C. (2004) · Endocrinología y Nutrición · doi:10.1016/s1575-0922(04)74656-2 · Cited by 3
ENDOTHELIAL DYSFUNCTION IN DIABETIC ANIMAL MODELS
Kobayashi, T., Matsumoto, T., & Kamata, K. (2004) · Journal of smooth muscle research Japanese section · doi:10.1540/heikatsukinzashi1997.8.j49 · Cited by 3
Ropivacaine Prevents the Activation of the NLRP3 Inflammasome Caused by High Glucose in HUVECs
Huang, X., Jiang, J., Huang, L., Ren, Q., Gao, X., & Yu, S. (2020) · ACS Omega · doi:10.1021/acsomega.0c03143 · Cited by 3
Too much TRAFfic at the crossroads of diabetes and endothelial dysfunction
Bagi, Z. A. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00614.2017 · Cited by 3
Al-Tikrity, N. Y., Algburi, F. S., & Beyatlı, A. (2020) · AIP conference proceedings · doi:10.1063/5.0030689 · Cited by 2
Morphological and Functional Characteristics of Blood and Lymphatic Vessels
Hantusch, B. (2024) · Learning materials in biosciences · doi:10.1007/978-3-031-64591-4_1 · Cited by 2
The role of PTP1B in cardiometabolic disorders and endothelial dysfunction
Sawali, M. A., Zahid, M., Abdelsalam, S. S., Al‐Zoubi, R. M., Shkoor, M., & Agouni, A. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2473024 · Cited by 2
“…homeostasis by producing vasoconstric-tors, vasodilators, anti-inflammatory, pro-inflammatory, anti-thrombotic, and pro-thrombotic factors [67,68]. individuals with diabetes are at an elevated risk of cvD, as both conditions converge at endothelial dysfunction, especially that generated by…”
Taguchi, K., Yonaiyama, H., Furukawa, T., Matsumoto, T., & Kobayashi, T. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2025.1734746 · Cited by 2
Maurer, G. S., O'NEILL, B. T., Jalal, D. I., & Stanhewicz, A. E. (2026) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01080.2025 · Cited by 2
Wilker, E. H., & Schwartz, J. D. (2010) · Royal Society of Chemistry eBooks · doi:10.1039/9781849732307-00143 · Cited by 2
Updates on Endoplasmic Reticulum
Favero, G. (2022) · Biochemistry · doi:10.5772/intechopen.100952 · Cited by 2
Tanaka, S., Sato, Y., Kitagawa, N., Shimodaira, O., Isobe, A., Omori, T., & Takamatsu, N. (2018) · International Journal of Prosthodontics and Restorative Dentistry · doi:10.5005/jp-journals-10019-1194 · Cited by 2
Effect of Surface Treatment on Longevity of Soft Liners: An in vitro and in vivo Study
Thakur, M. K., & Singh, D. K. (2018) · International Journal of Prosthodontics and Restorative Dentistry · doi:10.5005/jp-journals-10019-1196 · Cited by 2
Limb Revascularization in Patients with Diabetes Mellitus
Bokeria, L. A., Arakelyan, V. S., Папиташвили, В. Г., & Tsurtsumiya, S. S. (2019) · RUDN Journal of Medicine · doi:10.22363/2313-0245-2019-23-4-349-363 · Cited by 2
“This is achieved both due to impaired cell susceptibility to glucose, and due to the increased content of lipoproteins in the blood of patients with diabetes [19].”
BackgroundClinical considerations after endovascular therapy of peripheral artery disease
Giannopoulos, S., & Armstrong, E. J. (2021) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2021.1914590 · Cited by 2
Overtreatment in Implant Dentistry
Patil, P. G. (2018) · International Journal of Prosthodontics and Restorative Dentistry · doi:10.5005/jp-journals-10019-1193 · Cited by 2
Zou, M., & Wu, S. (2021) · Cardiology Discovery · doi:10.1097/cd9.0000000000000009 · Cited by 2
Sallam, N. A., Wang, B., & Laher, I. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02775-0 · Cited by 2
“…part, how short-term ET improved vasodilatation in the aortae of db/db mice since ROS interfere with NO signaling at multiple steps: eNOS activation, NO degradation, soluble guanylyl cyclase activation, and/ or contractile apparatus functioning (De Vriese et al. 2000; Félétou and Vanhoutte 2006).”
Noninvasive Orthogonal Polarization Spectral Imaging as Applied to Microvascular Studies in Mice
Nivoit, P., Chevrier, A. M., Lagarde, M., Renaudin, C., & Wiernsperger, N. F. (2004) · Journal of Diabetes Research · doi:10.1080/15438600490486859 · Cited by 2
Nitric Oxide, a Powerful Clinical Therapy
Meletis, C. D., & Zabriskie, N. (2006) · Alternative and Complementary Therapies · doi:10.1089/act.2006.12.59 · Cited by 2
Ultrastructural changes of pancreatic islets microcirculation in nonobese diabetic (NOD) mice.
Sachanonta, N., Pongponratn, E., Butraporn, R., Chaisri, U., Saelim, B., Sumeteewatanakul, V., Yamsaad, T., & Sawadrat, N. (2005) · PubMed · Cited by 2
Diabetes and Health Care: An Overview
Abhilash, M., & Augustine, R. (2014) · Apple Academic Press eBooks · doi:10.1201/b16415-6 · Cited by 2
Novel facts in pharmacology of endothelial dysfunction
Radenković, M., Stojanović, M., & Prostran, M. S. (2015) · Medicinska istrazivanja · doi:10.5937/medist1502018r · Cited by 2
Metadata
- Authors
- De Vriese, A. S., Verbeuren, T. J., Van de Voorde, J., Lameire, N. H., & Vanhoutte, P. M.
- Affiliations
- Institut Servier (FR)
- Ghent University (BE)
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-07
- Volume
- 130
- Issue
- 5
- Pages
- 963-974
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- PMC
- PMC1572156
- OpenAlex
- W2007880055
- Cited by
- 1,165
- References
- 114
- Citations by year
- 2026: 9 · 2025: 23 · 2024: 32 · 2023: 15 · 2022: 31 · 2021: 27 · 2020: 44 · 2019: 39 · 2018: 41 · 2017: 31 · 2016: 36 · 2015: 50 · 2014: 56 · 2013: 58 · 2012: 62
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- British Journal of Pharmacology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- endothelial dysfunction, diabetes mellitus, diabetic vascular disease, endothelium-derived relaxing factor, nitric oxide, prostacyclin, endothelium-derived hyperpolarizing factor, endothelium-dependent vasodilation, protein kinase C, polyol pathway, glycation, oxidative stress, hyperglycemia, ACE inhibitors, folic acid, vascular smooth muscle
- MeSH terms
- Animals, Biological Factors, Diabetes Mellitus, Endothelium, Vascular, Humans, Nitric Oxide, Protein Kinase C, Vasodilation, Signal Transduction, Endothelins, Glycation End Products, Advanced, Oxidative Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.